Your browser doesn't support javascript.
loading
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.
Armstrong, Andrew J; Geva, Ravit; Chung, Hyun Cheol; Lemech, Charlotte; Miller, Wilson H; Hansen, Aaron R; Lee, Jong-Seok; Tsai, Frank; Solomon, Benjamin J; Kim, Tae Min; Rolfo, Christian; Giranda, Vincent; Ren, Yixin; Liu, Fang; Kandala, Bhargava; Freshwater, Tomoko; Wang, Judy S.
Afiliación
  • Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, 27710, USA. andrew.armstrong@duke.edu.
  • Geva R; Division of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Chung HC; Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea.
  • Lemech C; Scientia Clinical Research, Randwick, NSW, Australia.
  • Miller WH; Segal Cancer Center, McGill University, Jewish General Hospital, Montreal, QC, Canada.
  • Hansen AR; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Lee JS; Seoul National University Bundang Hospital, Gyeonggi-Do, South Korea.
  • Tsai F; Honor Health, Scottsdale, AZ, USA.
  • Solomon BJ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Kim TM; Seoul National University Hospital, Seoul, South Korea.
  • Rolfo C; Center for Thoracic Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA.
  • Giranda V; Merck & Co., Inc, Rahway, NJ, USA.
  • Ren Y; Merck & Co., Inc, Rahway, NJ, USA.
  • Liu F; Merck & Co., Inc, Rahway, NJ, USA.
  • Kandala B; Merck & Co., Inc, Rahway, NJ, USA.
  • Freshwater T; Merck & Co., Inc, Rahway, NJ, USA.
  • Wang JS; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL, USA.
Invest New Drugs ; 42(3): 340-341, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38767685

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Invest New Drugs Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Invest New Drugs Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos